- Original article
- Open Access
Structural basis of stereospecific reduction by quinuclidinone reductase
© Takeshita et al.; licensee Springer. 2014
Received: 14 December 2013
Accepted: 28 December 2013
Published: 7 February 2014
Chiral molecule (R)-3-quinuclidinol, a valuable compound for the production of various pharmaceuticals, is efficiently synthesized from 3-quinuclidinone by using NADPH-dependent 3-quinuclidinone reductase (RrQR) from Rhodotorula rubra. Here, we report the crystal structure of RrQR and the structure-based mutational analysis. The enzyme forms a tetramer, in which the core of each protomer exhibits the α/β Rossmann fold and contains one molecule of NADPH, whereas the characteristic substructures of a small lobe and a variable loop are localized around the substrate-binding site. Modeling and mutation analyses of the catalytic site indicated that the hydrophobicity of two residues, I167 and F212, determines the substrate-binding orientation as well as the substrate-binding affinity. Our results revealed that the characteristic substrate-binding pocket composed of hydrophobic amino acid residues ensures substrate docking for the stereospecific reaction of RrQR in spite of its loose interaction with the substrate.
The chirality of chemical compounds is an important property for their availability as building blocks for pharmaceuticals and chemicals, including chemical catalysts, liquid crystals, flavors, agrochemicals, and medicines. As is often the case, only one optical isomer primarily or completely exhibits the intended activity. Therefore, it is necessary to develop methods to produce optically pure compounds for use in the industrial production of chiral compounds. Biotransformations using whole cells and enzyme-catalyzed reactions have been attempted for the production of various chiral compounds. The enzymatic asymmetric reduction of prochiral carbonyl compounds is a promising method for the production of chiral alcohols, because enzymes have certain advantages for use in chemical reactions under mild conditions and with chemo-, regio-, and stereo-selectivity (Hummel 1997; Kataoka et al. 2003; Goldberg et al. 2007). Structural information about useful enzymes would enable the generation of new enzymes exhibiting high activity, enhanced stability, and altered-coenzyme specificity, and would also enable elucidation of the detailed reaction mechanisms and substrate-binding specificities.
One of the chiral alcohols, (R)-3-quinuclidinol, is a useful compound applicable to the synthesis of various pharmaceuticals, such as talsaclidine and revatropate (Rzeszotarski et al. 1988; Bietti et al. 1990; Cross and Stobie 1993; Takeuchi et al. 1996; Alabaster 1997; Ward et al. 1998; Leusch et al. 2000; Ishihara et al. 2004). So far, chemical and biochemical methods have been applied to produce (R)-3-quinuclidinol (Stembach and Kaiser 1952; Rehavi et al. 1977; Muchmore 1993; Bossard 1997; Brieden 1998; Matsuyama and Hamatani 1998; Sato and Enomoto 1999; Nomoto et al. 2003; Yamamoto et al. 2003; Takenaka 2006), and most of these methods take the approach of resolving a racemic mixture. Recently, for the production of (R)-3-quinuclidinol, 3-quinuclidinone reductase (RrQR) was isolated from Rhodotorula rubra (Uzura et al. 2009). The purified enzyme from R. rubra is specific to NADPH as a coenzyme and stereospecifically produces the (R)-enantiomer of 3-quinuclidinol from 3-quinuclidinone. Furthermore, a coexpression system for the 3-quinuclidinone reductase and glucose dehydrogenase using Escherichia coli as a host was developed for the large-scale production of (R)-3-quinuclidinol. The system using the enzyme is superior to former kinetic resolution methods in that it has a higher molar yield, requires no substrate modification, and so on (Uzura et al. 2009).
Based on the amino acid similarity, RrQR belongs to the short-chain dehydrogenase/reductase family. Though the proteins in this family have low sequence identities, they share a similar α/β Rossmann-fold core. In contrast to the fold similarity, oxidoreductases, which make up the majority of the family, exhibit various substrate specificities (Oppermann et al. 2003), indicating that the mechanisms to accommodate structurally different substrates are diverse. The molecular identification and characterization of the enzymes of this family, which have diverse activities capable of producing useful molecules, would be helpful for the utilization of these enzymes. To elucidate the detailed molecular mechanism underlying the stereospecific reduction of the 3-quinuclidinone, we determined the crystal structure of RrQR in complex with NADPH. Modeling and mutation analyses of RrQR indicated a novel mechanism underlying the stereospecific reaction led by a characteristic interaction, explaining how optically pure (R)-3-quinuclidinol is synthesized from 3-quinuclidinone.
Materials and methods
Crystallization and structure determination of RrQR
Data collection and refinement statistics of the RrQR crystal
Unit-cell parameters (Å)
a = b = 91.3, c = 265.4
R merge (%)a,b
<I>/<σ(I) > a
Resolution range (Å)
r.m.s deviaton from ideal
Bond lengths (Å)
Bond angles (deg.)
Most favored regions (%)
Allowed regions (%)
3-Quinuclidinone reductase assay of wild-type and mutant RrQR enzymes
The reaction mixture comprised, in 2 ml, 500 mM 3-quinuclidinone · HCl, 566 mM glucose, 1.2 mg/ml NAD+ or NADP+, 0.4 mg/ml glucose dehydrogenase (Amano Enzymes, Nagoya, Japan), 200 mM potassium phosphate buffer (pH 7.0), and an appropriate amount of purified enzyme. After 20 h of incubation at 30°C, the reaction was terminated by addition of an equal volume of saturated Na2CO3, and then the formed 3-quinuclidinol was extracted with an equal volume of chloroform. The optical purity of 3-quinuclidinol was determined by gas-liquid chromatography analysis, as described previously (Uzura et al., 2009).
Mutations were introduced into the plasmid pET28a containing the RrQR gene. The mutant proteins were purified using a Ni-NTA column (Qiagen). The activities of the wild-type and mutant RrQR enzymes were analyzed as follows. The standard assay mixture was comprised of 2.5 ml, 125 mM 3-quinuclidinone-HCl, 350 μM NADPH, and 200 mM potassium phosphate buffer (pH 7.0), and the appropriate amount of the purified enzyme. After 2 min of incubation without the enzyme at 37°C, the reaction was started by adding the enzyme, and then the decrease in absorbance at 340 nm due to NADPH oxidation was determined. One unit of RrQR activity was defined as the amount catalyzing the oxidation of 1 μmol NADPH per min.
Coordinates and structure factors have been deposited in the Protein Data Bank with accession number 4O0L.
The crystal structure of RrQR was determined at 2.2-Å resolution and refined to a crystallographic R-factor of 0.192 and Rfree of 0.230 (Table 1 and Additional file 1: Table S1). The asymmetric unit of the crystal contains four protomers of RrQR. The final model includes residues 7‒272 for each protomer. There is no electron density for N-terminus residues 1‒6 in any of the four protomers, indicating that the region is flexible. The four protomers in the asymmetric unit are very similar to one another, with root-mean-square (r.m.s.) deviations of 0.20‒0.24 Å. A clear electron density for NADPH is observed in each protomer, and the structures of the four NADPH molecules in the asymmetric unit exhibit similar conformations.
The search for structurally homologous proteins was performed with the Dali server, and revealed several similar proteins: β-ketoacyl acyl carrier protein reductase (r.m.s. deviation of 1.2 Å for 229 Cα atoms (Fisher et al. 2000; PDB ID: 1edo)), trihydroxynaphthalene reductase (r.m.s. deviation of 1.2 Å for 219 Cα atoms (Liao et al. 2001; PDB ID: 1g0n)), and mannitol 2-dehydrogenase (r.m.s. deviation of 1.3 Å for 234 Cα atoms (Hörer et al. 2001; PDB ID: 1h5q)). Structural comparison showed that their core structures are almost superimposable, whereas remarkable structural diversities exist around the cleft (Figure 1c). The cleft is formed by the small lobe and a loop on the side opposite the lobe; this loop lies between βE and αF (residues 171-178). In the small lobe (S-lobe), RrQR has one helix αFG, whereas the other enzymes each have two helices. Upon the loop, the mannitol 2-dehydrogenase has a small antiparallel β-sheet, and the other enzymes have different structures. Thus, we named the loop the variable loop (V-loop) (Figure 1c). The deep cleft is located above the B-face of the nicotinamide ring, and it has been described as the substrate-binding site in SDR family proteins. Therefore, the diverse structures around the cleft could enable the family proteins to accommodate various substrates.
NADPH-binding mode of RrQR
Structure of the active site
Quinuclidinone reductase activities of the wild-type and mutant RrQR enzymes
Relative activity for 3-qinuclidinonea
Substrate-binding site and 3-quinuclidinone-binding model
A small space is found above the B-face of the nicotinamide ring, and is assumed to be the substrate-binding site. This small pocket, with a diameter of 7 Å and a depth of 8 Å, is formed by S166, I167, S168, N173, Q178, Y181, and F212 (Figure 3b). None of these residues is charged, and the most notable characteristic of the pocket is a hydrophobic wall composed of I167 and F212, located at about the bottom of the pocket.
The ketone group of the substrates has a trigonal planar configuration, with C-C-O and C-C-C bond angles of about 120˚. Therefore, the superimposition of the ketone group (C-CO-C) of 3-quinuclidinone to that of tropinone can be limited to two patterns, which are related by a 180° rotation about the carbonyl C-O bond axis (Figure 4a and b). The reaction is achieved through the proton transfer to the carbonyl group of a substrate from the catalytic residue tyrosine, and through the nucleophilic attack of the hydride of NADPH on the carbonyl carbon of the substrate. Thereby, the hydroxyl group of the product relocates to the side opposite that of the nicotinamide ring. The geometry presented in Figure 4a agrees with the catalytic reaction of RrQR, producing (R)-3-quinuclidinol from 3-quinuclidinone. On the other hand, the geometry in Figure 4b results in the production of another stereoisomer, (S)-3-quinuclidinol, which does not agree with the catalytic reaction of RrQR. The enzyme RrQR produces only (R)-3-quinuclidinol. Thus we describe the geometry in Figure 4a as a catalytic model and that in Figure 4b as a noncatalytic model.
We then evaluated the surroundings of the active site for the two models. The molecule 3-quinuclidinone contains a tertiary amine group, which has basic and hydrophilic properties due to a lone electron pair. In the catalytic model, the amine group is exposed to solvent, while on the opposite side, hydrophobic hydrocarbons of 3-quinuclidionone are buried in the small pocket and adjacent to the hydrophobic wall composed of I167 and F212, resulting in a stable state. On the other hand, in the noncatalytic model, the amine group is located adjacent to a hydrophobic wall composed of I167 and F212, and the hydrocarbons of 3-quinuclidinone are exposed to the solvent, thereby resulting in an unstable state. The differences between the two models can explain how the RrQR enzyme produces (R)-3-quinuclidinol prior to (S)-3-quinuclidinol from 3-quinuclidinone.
Critical residues in the substrate-binding site
The purified RrQR enzyme catalyzed the production of (R)-quinuclidinol from 3-quinuclidinone, with an enantiomeric excess of >99.9% (Uzura et al. 2009). The residues interacting with the substrate were predicted by the program Ligplot (Laskowski and Swindells 2011, Additional file 1: Figure S3), and Table 2 summarizes the results of the mutation analysis of the substrate-binding site. The analysis revealed that alanine mutations at hydrophobic residues I167 and F212 significantly affect the activity. The F212A and F212L mutants completely lost their catalytic activity, indicating the importance of the bulky hydrophobic property of phenylalanine. The accessible surface areas of phenylalanine and leucine are 30.9 Å2 and 26.9 Å2, respectively. Therefore, the bulky hydrophobic surface generated from the additional hydrocarbons plays a significant role in the activity. Similarly, the I167A mutant lost the activity, and the I167V mutant showed a significant decrease in the activity, to 24.5% of the wild type. With respect to the catalytic model presented in Figure 4a, the hydrocarbons of I167 and F212 would have direct hydrophobic interactions with the substrate, because the distances between the substrate and the side chains of I167 or F212 are within 4 Å.
In contrast to the mutations at the hydrophobic residues I167 and F212, the mutations at polar amino acid residues S168, N173 and Q178 did not exhibit significantly reduced activity (Table 2). In these mutations, the Km values are decreased and the kcat values are decreased, meaning that the affinities of the mutants are increased but the rates of the catalysis are decreased. The higher affinities of S168A, N173A and Q178A may be due to the increase of hydrophobicity favorable for the substrate binding. The reductions of the kcat value of these mutants suggest that the hydrogen network including catalytic residue S166 may be favorable for the reaction (Figure 4).
We subsequently refined the structure of the substrate-binding model by means of energy minimization, indicating that slight movements of residues I167, N173 and F212 enable the enzyme to adapt to 3-quinuclidinone (Figure 4c). Therefore, the active site of the enzyme has a preference for the substrate without large structural rearrangements.
The residues forming the substrate-binding pocket are located in the small lobe (residue F212) and on or near the variable loop (residues I167, S168, N173, and Q178). The two structural elements, the small lobe and the V-loop, are characteristic structural regions of the RrQR enzyme. Therefore, the stereospecific catalytic activity of RrQR would be achieved by this novel substrate-binding mechanism (Figure 4d).
The structure of RrQR is the first structure of quinuclidinone reductase shown to catalyze the stereo-specific reduction of 3-quinuclidinone. The RrQR enzyme produces (R)-3-quinuclidinol with more than 99.9% enantiomeric excess (Uzura et al. 2009). The angles of the hydride transfer reaction (C---H---C) have been suggested to be rigidly restricted (Wu and Houk 1987a; Wu and Houk 1987b). However, the structural model indicates that RrQR recognizes the substrate within a narrow area (Figure 4). In agreement with this, the K m value for 3-quinuclidinone (440 mM) is relatively high. Therefore, the RrQR enzyme would bind loosely to the substrate, but the substrate-binding site is sufficient to accommodate 3-quinuclidinone in one direction to produce the R-form of 3-quinuclidinol.
The substrate orientation is restricted by the circumstances of the catalytic site of RrQR. The substrate-binding pocket of RrQR is largely formed by the hydrophobic wall. The surface of the 3-quinuclidinone is divided into two parts, a hydrophilic face and hydrophobic face. Thus, the asymmetric reduction of 3-quinuclidinone is achieved by the ability of RrQR to discriminate the hydrophobic surface from the hydrophilic surface of 3-quinuclidinone. The hydrophobic residues of I167 and F212 function not only in the stereospecific substrate-binding but also in the substrate accommodation leading to the catalytic reaction (Table 2), and therefore we could not analyze the effect of the mutagenesis on the stereoselectivity. Several compounds, including 4-chloro-3-oxobutanoate and ketopantoyl lactone, are catalyzed by RrQR, but the optical purities of the products are reduced (Uzura et al. 2009). Therefore, the size and the chemical property of the catalytic pocket of RrQR is suitable for the binding of 3-quinuclidinone in the specific orientation.
Structural and mutation analyses of TR enzymes have indicated that the enzymes utilize electrostatic interactions between an amine group of the substrate and the carboxyl group of a Glu residue to determine the substrate-binding orientations (Nakajima et al. 1998; Nakajima et al. 1999). Similarly, levodione reductase also utilizes the electrostatic interaction between a positively charged surface of the substrate and a Glu residue to bind the substrate in the specific orientation (Sogabe et al. 2003). In contrast, the RrQR enzyme retains the stereospecific activity exhibited by the hydrophobic wall. Therefore, RrQR possesses a novel mechanism for the stereospecific reaction led by a characteristic interaction, in which the hydrophobicity of I167 and F212 plays a crucial role in the stereospecific reduction of 3-quinuclidinone.
In conclusion, we have described the structural analysis of an enzyme that catalyzes the stereospecific reduction of 3-quinuclidinone to (R)-3-quinuclidinol. The three-dimensional substrate-binding model and the mutation analysis indicate that the specific substrate-binding would be achieved through the interactions between hydrophobic residues and a hydrophobic substrate surface. The hydrophobic interactions would be crucial for the asymmetric reduction of 3-quinuclidinone. The reason for the low affinity for the substrate is that the compound 3-quinuclidinone is not the natural substrate for the enzyme. Therefore, it may be possible that tuning of the enzyme by genetic strategies and/or optimization of the reaction condition will yield an effective system for the expression of its maximum activity. The structural insights uncovered by this study will provide valuable information for investigations of enzymes that catalyze small cyclic molecules in specific orientations.
We thank the Beamline staff at Photon Factory for data collection. This work was performed with the approval of the Photon Factory Advisory Committee, Japan (Proposal No. 2008S2-001) and supported by the Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
- Alabaster VA: Discovery & development of selective M3 antagonists for clinical use. Life Sci 1997, 60: 1053–1060. 10.1016/S0024-3205(97)00047-7View ArticlePubMedGoogle Scholar
- Bietti G, Doods HN, Cereda E, Schiavone A, Donetti A, Giovanni B: New R(–)3-quinuclidinol derivatives. EP 404737. 1990.Google Scholar
- Bossard P: Verfahren zur Gewinnung von (R)-3-Chinuclidinol durch Racematspaltung von (R,S)-3-Chinuclidinol. DE 197 15 465. 1997.Google Scholar
- Brieden W: Process for the preparation of optically active 3-quinuclidinol. US Patent 1998, 5: 744,606.Google Scholar
- Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL: Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 1998, 54: 905–921.View ArticlePubMedGoogle Scholar
- Cross PE, Stobie A: Quinuclidine esters process and intermediate for their preparation and pharmaceutical compositions containing them. WO 9306098. 1993.Google Scholar
- DeLano WL: The PyMOL User’s Manual. San Carlos, CA: DeLano Scientific; 2002.Google Scholar
- Filling C, Berndt KD, Benach J, Knapp S, Prozorovski T, Nordling E, Ladenstein R, Jörnvall H, Oppermann U: Critical residues for structure and catalysis in short-chain dehydrogenases/reductases. J Biol Chem 2002, 277: 25677–25684. 10.1074/jbc.M202160200View ArticlePubMedGoogle Scholar
- Fisher M, Kroon JT, Martindale W, Stuitje AR, Slabas AR, Rafferty JB: The X-ray structure of Brassica napus β-keto acyl carrier protein reductase and its implications for substrate-binding and catalysis. Structure 2000, 8: 339–347. 10.1016/S0969-2126(00)00115-5View ArticlePubMedGoogle Scholar
- Goldberg K, Schroer K, Lütz S, Liese A: Biocatalytic ketone reduction-a powerful tool for the production of chiral alcohols–part I: processes with isolated enzymes. Appl Microbiol Biotechnol 2007, 76: 237–248. 10.1007/s00253-007-1002-0View ArticlePubMedGoogle Scholar
- Hess B, Kutzner C, van der Spoel D, Lindahl EJ: GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2008, 4: 435–447.View ArticleGoogle Scholar
- Hörer S, Stoop J, Mooibroek H, Baumann U, Sassoon J: The crystallographic structure of the mannitol 2-dehydrogenase NADP + binary complex from Agaricus bisporus . J Biol Chem 2001, 276: 27555–27561. 10.1074/jbc.M102850200View ArticlePubMedGoogle Scholar
- Hummel W: New alcohol dehydrogenases for the synthesis of chiral compounds. Adv Biochem Eng Biotechnol 1997, 58: 145–184.PubMedGoogle Scholar
- Ishihara T, Kakuta H, Moritani H, Ugawa T, Yanagisawa I: Synthesis and biological evaluation of quinuclidine derivatives incorporating phenothiazine moieties as squalene synthase inhibitors. Chem. Pharm. Bull. (Tokyo) 2004, 52: 1204–1209. 10.1248/cpb.52.1204View ArticleGoogle Scholar
- Jörnvall H, Persson B, Krook M, Atrian S, Gonzàlez-Duarte R, Jeffery J, Ghosh D: Short-chain dehydrogenases/reductases (SDR). Biochemistry 1995, 34: 6003–6013. 10.1021/bi00018a001View ArticlePubMedGoogle Scholar
- Kataoka M, Kita K, Wada M, Yasohara Y, Hasegawa J, Shimizu S: Novel bioreduction system for the production of chiral alcohols. Appl Microbiol Biotechnol 2003, 62: 437–445. 10.1007/s00253-003-1347-yView ArticlePubMedGoogle Scholar
- Kubota K, Nagata K, Okai M, Miyazono K, Soemphol W, Ohtsuka J, Yamamura A, Saichana N, Toyama H, Matsushita K, Tanokura M: The crystal structure of L -sorbose reductase from gluconobacter frateurii complexed with NADPH and L -sorbose. J Mol Biol 2011, 407: 543–555. 10.1016/j.jmb.2011.01.008View ArticlePubMedGoogle Scholar
- Laskowski RA, Swindells MB: LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 2011, 51: 2778–2786. 10.1021/ci200227uView ArticlePubMedGoogle Scholar
- Laskowski RA, MacArthur MW, Moss DS, Thornton JM: PROCHECK - a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993, 26: 283–291. 10.1107/S0021889892009944View ArticleGoogle Scholar
- Leusch A, Tröger W, Greischel A, Roth W: Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to man. Xenobiotica 2000, 30: 797–813. 10.1080/00498250050119853View ArticlePubMedGoogle Scholar
- Liao D, Basarab GS, Gatenby AA, Valent B, Jordan DB: Structures of trihydroxynaphthalene reductase-fungicide complexes: implications for structure-based design and catalysis. Structure 2001, 9: 19–27. 10.1016/S0969-2126(00)00548-7View ArticlePubMedGoogle Scholar
- Matsuyama A, Hamatani T: Processes for production of optical active quinuclidinol. EP 863212. 1998.Google Scholar
- McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ: Phaser crystallographic software. J Appl Cryst 2007, 40: 658–674. 10.1107/S0021889807021206View ArticleGoogle Scholar
- McRee DE: XtalView/Xfit–a versatile program for manipulating atomic coordinates and electron density. J Struct Biol 1999, 125: 156–165. 10.1006/jsbi.1999.4094View ArticlePubMedGoogle Scholar
- Muchmore DC: Enantiomeric enrichment of (R, S)-quinuclidinol. US Patent 1993, 5: 215,918.Google Scholar
- Murshudov GN, Vagin AA, Dodson EJ: Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 1997, 53: 240–255. 10.1107/S0907444996012255View ArticlePubMedGoogle Scholar
- Nakajima K, Yamashita A, Akama H, Nakatsu T, Kato H, Hashimoto T, Oda J, Yamada Y: Crystal structures of two tropinone reductases: different reaction stereospecificities in the same protein fold. Proc Natl Acad Sci USA 1998, 95: 4876–4881. 10.1073/pnas.95.9.4876PubMed CentralView ArticlePubMedGoogle Scholar
- Nakajima K, Kato H, Oda J, Yamada Y, Hashimoto T: Site-directed mutagenesis of putative substrate-binding residues reveals a mechanism controlling the different stereospecificities of two tropinone reductases. J Biol Chem 1999, 274: 16563–16568. 10.1074/jbc.274.23.16563View ArticlePubMedGoogle Scholar
- Nomoto F, Hirayama Y, Ikunaka M, Inoue T, Otsuka K: A practical chemoenzymatic process to access ( R )-quinuclidin-3-ol on scale. Tetrahedron Asymmetry 2003, 14: 1871–1877. 10.1016/S0957-4166(03)00363-XView ArticleGoogle Scholar
- Oppermann U, Filling C, Hult M, Shafqat N, Wu X, Lindh M, Shafqat J, Nordling E, Kallberg Y, Persson B, Jörnvall H: Short-chain dehydrogenases/reductases (SDR): the 2002 update. Chem Biol Interact 2003, 143–144: 247–253.View ArticlePubMedGoogle Scholar
- Otwinowski Z, Minor W: Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 1997, 276: 307–326.View ArticleGoogle Scholar
- Rehavi M, Maayani S, Sokolovsky M: Enzymatic resolution and cholinergic properties of (+/-)3-quinuclidinol derivatives. Life Sci 1977, 21: 1293–1302. 10.1016/0024-3205(77)90010-8View ArticlePubMedGoogle Scholar
- Rzeszotarski WJ, McPherson DW, Ferkany JW, Kinnier WJ, Noronha-Blob L, Kirkien-Rzeszotarski A: Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonists. J Med Chem 1988, 31: 1463–1466. 10.1021/jm00402a035View ArticlePubMedGoogle Scholar
- Sato E, Enomoto K: Process for producing optically active 3-quinuclidinol derivatives. EP 945518. 1999.Google Scholar
- Sogabe S, Yoshizumi A, Fukami TA, Shiratori Y, Shimizu S, Takagi H, Nakamori S, Wada M: The crystal structure and stereospecificity of levodione reductase from Corynebacterium aquaticum M-13. J Biol Chem 2003, 278: 19387–19395. 10.1074/jbc.M208146200View ArticlePubMedGoogle Scholar
- Stembach LH, Kaiser S: Antispasmodics. I. Bicyclic basic Alcohols. J Am Chem Soc 1952, 74: 2215–2218. 10.1021/ja01129a019View ArticleGoogle Scholar
- Takenaka M: Process for producing optically active 3-quinuclidinols. US Patent 20060047122. 2006.Google Scholar
- Takeshita D, Kataoka M, Miyakawa T, Miyazono KI, Uzura A, Nagata K, Shimizu S, Tanokura M: Crystallization and preliminary X-ray analysis of the NADPH-dependent 3-quinuclidinone reductase from Rhodotorula rubra . Acta Crystallogr Sect F 2009, 65: 645–647. 10.1107/S1744309109017588View ArticleGoogle Scholar
- Takeuchi M, Naito R, Hayakawa M, Okamoto Y, Yonetoku Y, Ikeda K, Isomura Y: EP 0801067. 1996.Google Scholar
- Uzura A, Nomoto F, Sakoda A, Nishimoto Y, Kataoka M, Shimizu S: Stereoselective synthesis of ( R )-3-quinuclidinol through asymmetric reduction of 3-quinuclidinone with 3-quinuclidinone reductase of Rhodotorula rubra . Appl Microbiol Biotechnol 2009, 83: 617–626. 10.1007/s00253-009-1902-2View ArticlePubMedGoogle Scholar
- Ward JS, Merritt L, Calligaro DO, Bymaster FP, Shannon HE, Mitch CH, Whitesitt C, Brunsting D, Sheardown MJ, Olesen PH, Swedberg MD, Jeppesen L, Sauerberg P: 1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonists. J Med Chem 1998, 41: 379–392. 10.1021/jm970125nView ArticlePubMedGoogle Scholar
- Wu YD, Houk KN: Transition structures for hydride transfers. J Am Chem Soc 1987, 109: 906–908. 10.1021/ja00237a050View ArticleGoogle Scholar
- Wu YD, Houk KN: Theoretical transition structures for hydride transfer to methyleneiminium ion from methylamine and dihydropyridine. On the nonlinearity of hydride transfers. J Am Chem Soc 1987, 109: 2226–2227.View ArticleGoogle Scholar
- Yamamoto H, Ueda M, Ritsuzui P, Hamatani T: Methods for producing optical active alcohols. EP 1318200. 2003.Google Scholar
- Yamashita A, Kato H, Wakatsuki S, Tomizaki T, Nakatsu T, Nakajima K, Hashimoto T, Yamada Y, Oda J: Structure of tropinone reductase-II complexed with NADP + and pseudotropine at 1.9 Å resolution: implication for stereospecific substrate binding and catalysis. Biochemistry 1999, 38: 7630–7637. 10.1021/bi9825044View ArticlePubMedGoogle Scholar
- Yamashita A, Endo M, Higashi T, Nakatsu T, Yamada Y, Oda J, Kato H: Capturing enzyme structure prior to reaction initiation: tropinone reductase-II-substrate complexes. Biochemistry 2003, 42: 5566–5573. 10.1021/bi0272712View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.